Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Clearside Biomedical Raises USD0.3 Million in Venture Financing 13
Clearside Biomedical Raises USD20 Million in Series C Financing 14
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 15
Clearside Biomedical Raises US$8 Million In Venture Financing 17
Clearside Biomedical Raises Additional Funds In Series A Financing 19
Partnerships 20
Clearside Biomedical Enters into Agreement with EyeKor 20
Santen Expands Research Agreement with Clearside Biomedical 21
Santen Enters Into Research Agreement With Clearside Biomedical 22
Licensing Agreements 23
NovaMedica Enters into Licensing Agreement with Clearside Biomedical 23
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 24
Equity Offering 25
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 25
Clearside BioMedical Prices Public Offering of Shares for USD36 Million 27
Clearside Biomedical Raises USD50.4 Million in IPO 29
Clearside BioMedical Inc – Key Competitors 31
Clearside BioMedical Inc – Key Employees 32
Clearside BioMedical Inc – Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Financial Announcements 34
Aug 08, 2018: Clearside Biomedical announces second quarter 2018 financial results and provides corporate update 34
May 09, 2018: Clearside Biomedical Announces First Quarter 2018 Financial Results 37
Mar 14, 2018: Clearside Biomedical Reports Fourth Quarter 2017 Financial Results 38
Nov 08, 2017: Clearside Biomedical Announces Third Quarter 2017 Financial Results and Provides Corporate Update 41
Aug 09, 2017: Clearside Biomedical Announces Second Quarter 2017 Financial Results and Provides Corporate Update 43
May 10, 2017: Clearside Biomedical Announces First Quarter 2017 Financial Results and Provides Corporate Update 45
Mar 14, 2017: Clearside Biomedical Announces Fourth Quarter And Full Year 2016 Financial Results 47
Corporate Communications 49
Sep 27, 2018: Clearside Biomedical appoints Jeffrey Edwards to board of directors 49
Sep 11, 2018: Clearside Biomedical names Leslie Zacks as General Counsel and Chief Compliance Officer 50
Feb 26, 2018: Clearside Biomedical Appoints William Humphries As Board Chairman And Brion Raymond As Chief Commercial Officer 51
Aug 08, 2017: Clearside Biomedical Announces Changes to its Board of Directors 53
Jan 04, 2017: Clearside Biomedical Appoints Richard Beckman, M.D., as Chief Medical Officer 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Clearside Biomedical Raises USD0.3 Million in Venture Financing 13
Clearside Biomedical Raises USD20 Million in Series C Financing 14
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 15
Clearside Biomedical Raises US$8 Million In Venture Financing 17
Clearside Biomedical Raises Additional Funds In Series A Financing 19
Clearside Biomedical Enters into Agreement with EyeKor 20
Santen Expands Research Agreement with Clearside Biomedical 21
Santen Enters Into Research Agreement With Clearside Biomedical 22
NovaMedica Enters into Licensing Agreement with Clearside Biomedical 23
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 24
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 25
Clearside BioMedical Prices Public Offering of Shares for USD36 Million 27
Clearside Biomedical Raises USD50.4 Million in IPO 29
Clearside BioMedical Inc, Key Competitors 31
Clearside BioMedical Inc, Key Employees 32
List of Figures
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10